the foundation and friends of the royal botanic gardens, kew Company Information
Company Number
02499006
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Activities of other membership organisations n.e.c.
Registered Address
the herbarium kew green, richmond, TW9 3AE
Website
http://kew.orgthe foundation and friends of the royal botanic gardens, kew Estimated Valuation
Pomanda estimates the enterprise value of THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW at £8.2m based on a Turnover of £7.5m and 1.09x industry multiple (adjusted for size and gross margin).
the foundation and friends of the royal botanic gardens, kew Estimated Valuation
Pomanda estimates the enterprise value of THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW at £36.5m based on an EBITDA of £5m and a 7.33x industry multiple (adjusted for size and gross margin).
the foundation and friends of the royal botanic gardens, kew Estimated Valuation
Pomanda estimates the enterprise value of THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW at £57m based on Net Assets of £25.1m and 2.28x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Foundation And Friends Of The Royal Botanic Gardens, Kew Overview
The Foundation And Friends Of The Royal Botanic Gardens, Kew is a live company located in richmond, TW9 3AE with a Companies House number of 02499006. It operates in the activities of other membership organizations n.e.c. sector, SIC Code 94990. Founded in May 1990, it's largest shareholder is unknown. The Foundation And Friends Of The Royal Botanic Gardens, Kew is a mature, mid sized company, Pomanda has estimated its turnover at £7.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Foundation And Friends Of The Royal Botanic Gardens, Kew Health Check
Pomanda's financial health check has awarded The Foundation And Friends Of The Royal Botanic Gardens, Kew a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 1 areas for improvement. Company Health Check FAQs


5 Strong

3 Regular

1 Weak

Size
annual sales of £7.5m, make it larger than the average company (£417.8k)
£7.5m - The Foundation And Friends Of The Royal Botanic Gardens, Kew
£417.8k - Industry AVG

Growth
3 year (CAGR) sales growth of 42%, show it is growing at a faster rate (7.5%)
42% - The Foundation And Friends Of The Royal Botanic Gardens, Kew
7.5% - Industry AVG

Production
with a gross margin of 87.9%, this company has a comparable cost of product (87.9%)
87.9% - The Foundation And Friends Of The Royal Botanic Gardens, Kew
87.9% - Industry AVG

Profitability
an operating margin of 66.2% make it more profitable than the average company (1.5%)
66.2% - The Foundation And Friends Of The Royal Botanic Gardens, Kew
1.5% - Industry AVG

Employees
with 145 employees, this is above the industry average (10)
- The Foundation And Friends Of The Royal Botanic Gardens, Kew
10 - Industry AVG

Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- The Foundation And Friends Of The Royal Botanic Gardens, Kew
£27k - Industry AVG

Efficiency
resulting in sales per employee of £51.9k, this is equally as efficient (£52k)
- The Foundation And Friends Of The Royal Botanic Gardens, Kew
£52k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Foundation And Friends Of The Royal Botanic Gardens, Kew
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - The Foundation And Friends Of The Royal Botanic Gardens, Kew
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Foundation And Friends Of The Royal Botanic Gardens, Kew
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 108 weeks, this is less cash available to meet short term requirements (162 weeks)
108 weeks - The Foundation And Friends Of The Royal Botanic Gardens, Kew
162 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 13.3%, this is a lower level of debt than the average (18.5%)
13.3% - The Foundation And Friends Of The Royal Botanic Gardens, Kew
18.5% - Industry AVG
THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW financials

The Foundation And Friends Of The Royal Botanic Gardens, Kew's latest turnover from March 2024 is £7.5 million and the company has net assets of £25.1 million. According to their latest financial statements, we estimate that The Foundation And Friends Of The Royal Botanic Gardens, Kew has 145 employees and maintains cash reserves of £8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7,521,000 | 4,829,000 | 4,280,000 | 2,601,000 | 5,069,000 | 7,707,000 | 11,591,000 | 21,921,000 | 25,167,000 | 28,840,000 | 15,853,000 | 11,928,000 | 10,678,000 | 7,796,000 | 8,963,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | 1,945,000 | 1,180,000 | |||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 3,956,000 | 1,253,000 | -4,452,000 | -736,000 | -2,865,000 | -763,000 | -11,408,000 | -3,034,000 | 3,717,000 | 14,264,000 | 1,774,000 | -766,000 | 4,278,000 | 1,945,000 | 1,180,000 |
Tax | |||||||||||||||
Profit After Tax | 3,956,000 | 1,253,000 | -4,452,000 | -736,000 | -2,865,000 | -763,000 | -11,408,000 | -3,034,000 | 3,717,000 | 14,264,000 | 1,774,000 | -766,000 | 4,278,000 | 1,945,000 | 1,180,000 |
Dividends Paid | |||||||||||||||
Retained Profit | 3,956,000 | 1,253,000 | -4,452,000 | -736,000 | -2,865,000 | -763,000 | -11,408,000 | -3,034,000 | 3,717,000 | 14,264,000 | 1,774,000 | -766,000 | 4,278,000 | 1,945,000 | 1,180,000 |
Employee Costs | 564,000 | 2,467,000 | 2,441,000 | 2,140,000 | 1,846,000 | 1,844,000 | 1,600,000 | 1,486,000 | 1,510,000 | ||||||
Number Of Employees | 47 | 49 | 47 | 87 | 41 | 42 | 36 | 41 | 44 | ||||||
EBITDA* | 1,945,000 | 1,201,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 35,000 | 31,000 | 7,018,000 | 28,000 | 92,000 | 1,000 | 8,000 | ||||||||
Intangible Assets | |||||||||||||||
Investments & Other | 15,198,000 | 14,067,000 | 11,410,000 | 21,651,000 | 20,092,000 | 20,886,000 | 26,866,000 | 35,125,000 | 28,759,000 | 21,008,000 | 16,697,000 | 5,280,000 | 4,717,000 | 4,527,000 | 5,759,000 |
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 15,198,000 | 14,067,000 | 11,410,000 | 21,651,000 | 20,092,000 | 20,886,000 | 26,866,000 | 35,160,000 | 28,790,000 | 28,026,000 | 16,725,000 | 5,372,000 | 4,717,000 | 4,528,000 | 5,767,000 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 1,589,000 | 2,272,000 | 3,109,000 | 313,000 | 557,000 | 255,000 | 49,000 | ||||||||
Group Debtors | 18,000 | 90,000 | 55,000 | 68,000 | 114,000 | 11,000 | 77,000 | 22,000 | 50,000 | ||||||
Misc Debtors | 5,663,000 | 3,861,000 | 1,049,000 | 1,265,000 | 1,574,000 | 4,776,000 | 130,000 | 317,000 | 2,922,000 | 249,000 | 605,000 | 208,000 | 8,000 | 78,000 | 1,000 |
Cash | 8,044,000 | 3,200,000 | 11,019,000 | 2,896,000 | 4,845,000 | 3,826,000 | 2,309,000 | 4,675,000 | 11,957,000 | 8,928,000 | 8,415,000 | 17,766,000 | 19,514,000 | 15,317,000 | 10,279,000 |
misc current assets | 554,000 | ||||||||||||||
total current assets | 13,707,000 | 7,061,000 | 12,068,000 | 4,161,000 | 6,419,000 | 8,602,000 | 4,046,000 | 7,908,000 | 14,934,000 | 12,354,000 | 9,447,000 | 18,542,000 | 19,854,000 | 15,417,000 | 10,379,000 |
total assets | 28,905,000 | 21,128,000 | 23,478,000 | 25,812,000 | 26,511,000 | 29,488,000 | 30,912,000 | 43,068,000 | 43,724,000 | 40,380,000 | 26,172,000 | 23,914,000 | 24,571,000 | 19,945,000 | 16,146,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 7,000 | 207,000 | 31,000 | 135,000 | 120,000 | 232,000 | 268,000 | 480,000 | 256,000 | ||||||
Group/Directors Accounts | 3,838,000 | 447,000 | 3,820,000 | 1,929,000 | 2,794,000 | 2,596,000 | 3,378,000 | 3,122,000 | 2,235,000 | 2,083,000 | 2,689,000 | 2,097,000 | 2,698,000 | 2,000,000 | 642,000 |
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 15,000 | 17,000 | 17,000 | 19,000 | 18,000 | 46,000 | 44,000 | 455,000 | 467,000 | 370,000 | 243,000 | 527,000 | 280,000 | 151,000 | 177,000 |
total current liabilities | 3,853,000 | 464,000 | 3,837,000 | 1,948,000 | 2,812,000 | 2,649,000 | 3,422,000 | 3,784,000 | 2,733,000 | 2,588,000 | 3,052,000 | 2,856,000 | 3,246,000 | 2,631,000 | 1,075,000 |
loans | 276,000 | ||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 276,000 | ||||||||||||||
total liabilities | 3,853,000 | 464,000 | 3,837,000 | 1,948,000 | 2,812,000 | 2,649,000 | 3,422,000 | 3,784,000 | 2,733,000 | 2,588,000 | 3,052,000 | 2,856,000 | 3,246,000 | 2,907,000 | 1,075,000 |
net assets | 25,052,000 | 20,664,000 | 19,641,000 | 23,864,000 | 23,699,000 | 26,839,000 | 27,490,000 | 39,284,000 | 40,991,000 | 37,792,000 | 23,120,000 | 21,058,000 | 21,325,000 | 17,038,000 | 15,071,000 |
total shareholders funds | 25,052,000 | 20,664,000 | 19,641,000 | 23,864,000 | 23,699,000 | 26,839,000 | 27,490,000 | 39,284,000 | 40,991,000 | 37,792,000 | 23,120,000 | 21,058,000 | 21,325,000 | 17,038,000 | 15,071,000 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,945,000 | 1,180,000 | |||||||||||||
Depreciation | 28,000 | 29,000 | 20,000 | 15,000 | 2,000 | 1,000 | 21,000 | ||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 1,802,000 | 2,812,000 | -216,000 | -309,000 | -3,202,000 | 3,039,000 | -942,000 | -298,000 | -449,000 | 2,394,000 | 256,000 | 436,000 | 240,000 | 100,000 | |
Creditors | -7,000 | 7,000 | -207,000 | 176,000 | -104,000 | 15,000 | -112,000 | -36,000 | -212,000 | 224,000 | 256,000 | ||||
Accruals and Deferred Income | -2,000 | -2,000 | 1,000 | -28,000 | 2,000 | -411,000 | -12,000 | 97,000 | 127,000 | -284,000 | 247,000 | 129,000 | -26,000 | 177,000 | |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 2,143,000 | 1,534,000 | |||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | 8,410,000 | -5,071,000 | -834,000 | -3,913,000 | -11,169,000 | -158,000 | -181,000 | 1,255,000 | 40,000 | ||||||
Change in Investments | 1,131,000 | 2,657,000 | -10,241,000 | 1,559,000 | -794,000 | -5,980,000 | -8,259,000 | 6,366,000 | 7,751,000 | 4,311,000 | 11,417,000 | 563,000 | 190,000 | -1,232,000 | 5,759,000 |
cash flow from investments | -1,131,000 | -2,657,000 | 10,241,000 | -1,559,000 | 794,000 | 5,980,000 | 16,669,000 | -11,437,000 | -8,585,000 | -8,224,000 | -22,586,000 | -721,000 | -371,000 | 2,487,000 | -5,719,000 |
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 3,391,000 | -3,373,000 | 1,891,000 | -865,000 | 198,000 | -782,000 | 256,000 | 887,000 | 152,000 | -606,000 | 592,000 | -601,000 | 698,000 | 1,358,000 | 642,000 |
Other Short Term Loans | |||||||||||||||
Long term loans | -276,000 | 276,000 | |||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 3,823,000 | -3,603,000 | 2,120,000 | 36,000 | -77,000 | -670,000 | -130,000 | 2,214,000 | -366,000 | -198,000 | 880,000 | -102,000 | 431,000 | 1,656,000 | 14,533,000 |
cash and cash equivalents | |||||||||||||||
cash | 4,844,000 | -7,819,000 | 8,123,000 | -1,949,000 | 1,019,000 | 1,517,000 | -2,366,000 | -7,282,000 | 3,029,000 | 513,000 | -9,351,000 | -1,748,000 | 4,197,000 | 5,038,000 | 10,279,000 |
overdraft | |||||||||||||||
change in cash | 4,844,000 | -7,819,000 | 8,123,000 | -1,949,000 | 1,019,000 | 1,517,000 | -2,366,000 | -7,282,000 | 3,029,000 | 513,000 | -9,351,000 | -1,748,000 | 4,197,000 | 5,038,000 | 10,279,000 |
the foundation and friends of the royal botanic gardens, kew Credit Report and Business Information
The Foundation And Friends Of The Royal Botanic Gardens, Kew Competitor Analysis

Perform a competitor analysis for the foundation and friends of the royal botanic gardens, kew by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other mid companies, companies in TW9 area or any other competitors across 12 key performance metrics.
the foundation and friends of the royal botanic gardens, kew Ownership
THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW group structure
The Foundation And Friends Of The Royal Botanic Gardens, Kew has no subsidiary companies.
Ultimate parent company
THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW
02499006
the foundation and friends of the royal botanic gardens, kew directors
The Foundation And Friends Of The Royal Botanic Gardens, Kew currently has 5 directors. The longest serving directors include Mr Jan Pethick (Mar 2017) and Ms Kristina Kenworthy (Dec 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jan Pethick | England | 77 years | Mar 2017 | - | Director |
Ms Kristina Kenworthy | United Kingdom | 66 years | Dec 2018 | - | Director |
Ms Jane Reeves | England | 61 years | Jul 2020 | - | Director |
Jantiene Klein Roseboom Van Der Veer | United Kingdom | 63 years | Jul 2021 | - | Director |
Mr Steve Almond | 68 years | Nov 2023 | - | Director |
P&L
March 2024turnover
7.5m
+56%
operating profit
5m
0%
gross margin
88%
-1.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
25.1m
+0.21%
total assets
28.9m
+0.37%
cash
8m
+1.51%
net assets
Total assets minus all liabilities
the foundation and friends of the royal botanic gardens, kew company details
company number
02499006
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
94990 - Activities of other membership organisations n.e.c.
incorporation date
May 1990
age
35
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
the friends of the royal botanic gardens, kew (December 1994)
accountant
-
auditor
HAYSMACINTYRE LLP
address
the herbarium kew green, richmond, TW9 3AE
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
the foundation and friends of the royal botanic gardens, kew Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to the foundation and friends of the royal botanic gardens, kew. Currently there are 1 open charges and 0 have been satisfied in the past.
the foundation and friends of the royal botanic gardens, kew Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE FOUNDATION AND FRIENDS OF THE ROYAL BOTANIC GARDENS, KEW. This can take several minutes, an email will notify you when this has completed.
the foundation and friends of the royal botanic gardens, kew Companies House Filings - See Documents
date | description | view/download |
---|